David Warncken- Presentations & Publications

Publications:

  1. Rowland, A, van Dyk, M, Warncken, D, Mangoni, A, Sorich, M, & Rowland, A (2017). “Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol”. British Journal of Clinical Pharmacology, doi: 1111/bcp.13478.
  2. Rosser, A, Warncken, D, Mohan, T, & Bastiampillai, T (2014). “The role of Transcranial Magnetic Stimulation in treatment resistant depression”. Australian & New Zealand Journal of Psychiatry, 49(5) pp.484.

Presentations

  1. Antioch, K, Asche, C, Dugdale, P, Schwarz, M, Bristow, Z, Pan, Y, Sherwin, F, Kuek, A, Anderson, N, Warncken, D, Richardson, L (2018). “Cost Effectiveness of Prostate Cancer (PCa) screening and diagnostic strategies: International Lessons for Clinical Practice Guidelines (CPGs)”. Presented by Dr Kathryn Antioch (Poster) at NHMRC Research Translation Symposium, November 2018.
  2. Vanderstelt, S, van Zanten, M, Bryson, K, Hancock, D, Herbert, A, Lloyd-Fox, B, Walley, R, Warncken, D, Viehoff, P, & Piller, N (2015). “ICF Core Set Development for Lymphoedema in Australia”. Paper presented at the Survivorship Conference 2015, Adelaide South Australia.